Stay updated on Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial

Sign up to get notified when there's something new on the Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page’s footer revision identifier changed from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-18T01:07:55.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov study record for the GEN-003 HSV-2 vaccine trial is now available, with details on its completed Phase 2 design, participant criteria, study locations, and outcome measures.
    Difference
    54%
    Check dated 2026-11-10T19:53:46.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T20:24:27.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    A site-wide NIH notice about the terminology transition appears above the error page, and the site revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T20:47:25.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1. The study record page continues to display a 403 Forbidden message.
    Difference
    0.2%
    Check dated 2026-10-06T20:12:09.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study record. This indicates access is blocked to the NCT02515175 page rather than any update to the study content.
    Difference
    19%
    Check dated 2026-09-22T22:22:44.000Z thumbnail image

Stay in the know with updates to Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial page.